Androsta-1,4,6-triene-3,17-dione powder
CAS Non.: 633-35-2
EINECS: 214-983-0
M. F. : C19H22O2
M.W.: 282.37678
Liquefactio Point: 164-165
Assay: 99%
Aspectus: album crystallinum pulveris
1,4,6-Androstatrien-3,17-dione (ATD) is considered to be a potent irreversible aromatase inhibitor that is useful for inhibiting estrogen biosynthesis by binding and inactivating aromatase in peripheral and adipose tissues in a permanent manner.
1,4,6-Androstatrien-3,17-dione (ATD) is used to control estrogen synthesis and present in some of the over-the-counter muscle-enhancing and bodybuilding supplements. It increases testosterone levels in the body in an indirect manner and is therefore considered to be one of the favorite supplement among professional athletes and bodybuilders.
1,4,6-Androstatrien-3,17-dione (ATD) offers benefits such as improvements in male fertility, modus levels, correpta recuperatio si urit aut gravi trauma et excitanda in developing Mammalia. Efficacior existimatur substantia anti-aromatasis quam multae aliae et sufficere ad augendam testosteronum gradus in corpore sine concomitante reductione gradus estrogenii in hominibus..
Adhiberi potest pro hormone vel androgen in reposito therapia in hominibus sine consequens diminutionem concomitantis in campis endogenosis estrogenis cum modo orali vel transdermali in dosages e vndique administrato 25-150 mg/diei.
It is used to control estrogen synthesis and present in some of the over-the-counter muscle-enhancing and bodybuilding supplements. It increases testosterone levels in the body in an indirect manner and is therefore considered to be one of the favorite supplement among professional athletes and bodybuilders.
1,4,6-Androstatrien-3,17-dione (ATD) offers benefits such as improvements in male fertility, modus levels, correpta recuperatio si urit aut gravi trauma et excitanda in developing Mammalia. Efficacior existimatur substantia anti-aromatasis quam multae aliae et sufficere ad augendam testosteronum gradus in corpore sine concomitante reductione gradus estrogenii in hominibus.. Adhiberi potest pro hormone vel androgen in reposito therapia in hominibus sine consequens diminutionem concomitantis in campis endogenosis estrogenis cum modo orali vel transdermali in dosages e vndique administrato 25-150 mg/diei.
